AI assistant
Hannover Rueck SE — Earnings Release 2017
Aug 10, 2017
197_ip_2017-08-10_7456cb60-4957-4a22-b463-40b25e657055.pdf
Earnings Release
Open in viewerOpens in your device viewer
Conference Call on Half-yearly Report 2017
Hannover, 10 August 2017
Half-year results in line with full-year targets
Group
| | Gross written premium: | EUR 8,998 m. (+8.6%) | | Attractive GWP growth (f/x adjusted +8.7%) |
|---|---|---|---|---|
| | Net premium earned: | EUR 7,523 m. (+5.0%) | | NPE f/x-adj. growth of +4.9% |
| | EBIT: | EUR 799 m. | | EBIT and net income driven by strong investment performance as well as solid earnings contribution |
| | Group net income: | EUR 535 m. | from P&C | |
| | RoE: | 12.2% | | RoE remains well above our minimum target |
| | BVPS: | EUR 71.00 | | BVPS decreased by -4.8% due to capital management measures and strong Euro |
| Property & Casualty R/I | Life & Health R/I | Investments | |||
|---|---|---|---|---|---|
| EBIT: | EUR 634 m. | EBIT: | EUR 165 m. | NII: RoI from AuM: |
EUR 779 m. 3.2% |
| Combined ratio slightly inflated mainly due to growth in Structured R/I Net major losses of EUR 123 m. (2.8% of NPE) well below expected level Accelerated GWP growth (f/x adjusted +16.9%) mainly driven by new business in Structured R/I |
claims from legacy US mortality Strong earnings growth from Financial solutions business GWP development in line with expectations (f/x adjusted -1.5%) |
Continuously higher than expected | RoI well above full-year target (>2.7%) Ordinary investment income higher mainly due to strong contribution from Private Equity and Real Estate Strengthening of EUR leads to decrease in AUM (-3.4%) |
Overall satisfying business development Strong growth in Property & Casualty reinsurance
| Group figures in m. EUR | Q2/2016 | Q2/2017 | Δ | 1H/2016 | 1H/2017 | Δ |
|---|---|---|---|---|---|---|
| Gross written premium | 4,020 | 4,451 | 10.7% | 8,284 | 8,998 | 8.6% |
| Net premium earned | 3,625 | 3,791 | 4.6% | 7,167 | 7,523 | 5.0% |
| Net underwriting result | (39) | (55) | 43.1% | (3) | (79) | - |
| - Incl. funds withheld | 53 | (5) | -109.2% | 173 | 45 | -74.2% |
| Net investment income | 379 | 387 | 2.1% | 745 | 779 | 4.6% |
| - From assets under own mgmt. | 286 | 336 | 17.3% | 569 | 656 | 15.3% |
| - From funds withheld | 92 | 50 | -45.2% | 176 | 123 | -29.7% |
| Other income and expenses | 1 | 68 | - | 5 | 99 | - |
| Operating profit/loss (EBIT) | 340 | 400 | 17.3% | 747 | 799 | 7.0% |
| Interest on hybrid capital | (18) | (18) | 0.3% | (36) | (36) | -0.2% |
| Net income before taxes | 322 | 381 | 18.3% | 711 | 764 | 7.4% |
| Taxes | (93) | (94) | 1.2% | (195) | (190) | -2.6% |
| Net income | 230 | 287 | 25.2% | 516 | 574 | 11.1% |
| - Non-controlling interests | 13 | 17 | 35.7% | 28 | 39 | 36.8% |
| Group net income | 217 | 270 | 24.6% | 488 | 535 | 9.6% |
| Retention | 90.6% | 90.9% | 89.8% | 90.3% | ||
| EBIT margin (EBIT/Net premium earned) | 9.4% | 10.5% | 10.4% | 10.6% | ||
| Tax ratio | 28.8% | 24.6% | 27.4% | 24.9% | ||
| Earnings per share (in EUR) | 1.80 | 2.24 | 4.05 | 4.44 |
Continued positive operating cash flow AuM -3.4% driven by strengthening of the Euro and dividend payment
Shareholders' equity decreased despite favourable earnings Driven by dividend payment and negative effects from currency translation
Solid underwriting result in a competitive environment Remarkable growth mainly driven by tailor-made structured R/I
| Property & Casualty R/I in m. EUR | Q2/2016 | Q2/2017 | 1H/2016 | 1H/2017 | YTD | ||
|---|---|---|---|---|---|---|---|
| Gross written premium | 2,125 | 2,613 | 4,627 | 5,427 | GWP f/x adjusted +16.9%, mainly from structured R/I; diversified growth in other areas |
||
| Net premium earned | 1,877 | 2,147 | 3,838 | 4,313 | NPE f/x adjusted +11.8% |
||
| Net underwriting result incl. funds withheld |
74 | 55 | 178 | 151 | Major loss expectation reflected in reserves as usual |
||
| Combined ratio incl. interest on funds withheld |
96.1% | 97.4% | 95.4% | 96.5% | Reserve increase due to Ogden tables of EUR 291 m. compensated by reserve releases |
||
| Net investment income from assets under own management |
201 | 235 | 405 | 474 | Favourable ordinary investment income |
||
| Other income and expenses | (12) | 34 | (20) | 10 | Other income and expenses benefited from positive currency effects |
||
| Operating profit/loss (EBIT) | 263 | 324 | 563 | 634 | EBIT growth of 12.7% in line with volume growth |
||
| Tax ratio | 29.7% | 24.3% | 28.2% | 24.5% | EBIT margin of 14.7% (1H/2016: 14.7%) well above target |
||
| Group net income | 174 | 229 | 378 | 444 | |||
| Earnings per share (in EUR) | 1.44 | 1.90 | 3.14 | 3.68 |
Major losses well below budget for 1H/2017 Remaining unused large loss budget of EUR 702 m. for the year
Natural and man-made catastrophe losses* in m. EUR
* Up to 2011 claims over EUR 5 m. gross, from 2012 onwards claims over EUR 10 m. gross
Overall very benign large loss experience in 1H/2017 Absence of major losses in Q2/2017
| Catastrophe losses* in m. EUR | Date | Gross | Net |
|---|---|---|---|
| Storm / Tornados, USA | 18 - 21 Jan | 12.6 | 11.0 |
| Wildfires, Chile | 21 Jan - 3 Feb | 19.8 | 19.8 |
| Cyclone "Debbie", Australia | 27 - 28 Mar | 55.5 | 46.4 |
| 3 Natural catastrophes | 87.9 | 77.2 | |
| 1 Property claim | 35.0 | 29.2 | |
| 1 Credit claim | 16.4 | 16.4 | |
| 5 Major losses | 139.4 | 122.9 |
* Natural catastrophes and other major losses in excess of EUR 10 m. gross
Overall profitability above cost of capital Change in Ogden rate reflected in UK, Ireland, London market and direct
| 1H/2017: Combined Ratio vs. MtCR | EBIT margin |
|||||||
|---|---|---|---|---|---|---|---|---|
| Target | North America* | 98.1% | 20.6% | |||||
| markets | Continental Europe* | 87.7% | 24.4% | |||||
| Marine | 74.3% | 40.6% | ||||||
| Aviation | 70.0% | 45.4% | ||||||
| Specialty | Credit, surety and political risks | 90.2% | 18.5% | |||||
| lines worldwide |
UK, Ireland, London market and direct |
150.4% | -35.2% | |||||
| Facultative R/I | 86.3% | 25.0% | ||||||
| Worldwide Treaty* R/I | 98.0% | 10.4% | ||||||
| Global R/I |
Cat XL | 54.7% | 64.3% | |||||
| Structured R/I and ILS | 97.5% | 5.8% | ||||||
| Total | 96.5% | 14.7% | ||||||
| 0% | 20% | 40% | 60% | 80% | 100% | 120% |
MtCR = Maximum tolerable Combined Ratio Combined Ratio
* All lines of Property & Casualty reinsurance except those stated separately
Overall profitability in Life & Health below expectation Strong earnings contribution from Financial solutions
| Life & Health R/I in m. EUR | Q2/2016 | Q2/2017 | 1H/2016 | 1H/2017 | YTD |
|---|---|---|---|---|---|
| Gross written premium | 1,895 | 1,838 | 3,656 | 3,570 | GWP f/x-adjusted -1.5%, reduced premium volume from large-volume treaties partly offset |
| Net premium earned | 1,747 | 1,644 | 3,328 | 3,210 | by diversified growth in other areas NPE f/x-adjusted growth -3.1% |
| Net underwriting result incl. funds withheld |
(20) | (60) | (5) | (106) | Technical result impacted by legacy US mortality biz (~EUR 50 m. below expectation) |
| Net investment income from assets under own management |
80 | 100 | 158 | 180 | Strong investment income Increased other income and expenses due to |
| Other income and expenses | 13 | 36 | 26 | 91 | strong contribution from deposit accounted treaties (1H/2017: EUR 93 m.) |
| Operating profit/loss (EBIT) | 74 | 75 | 179 | 165 | EBIT margins: |
| EBIT margin | 4.2% | 4.6% | 5.4% | 5.1% | • Financial solutions: 29.9% • Longevity: 2.3% |
| Tax ratio | 26.4% | 28.6% | 25.8% | 28.5% | • Mortality and Morbidity: 1.0% |
| Group net income | 53 | 54 | 131 | 114 | |
| Earnings per share (in EUR) | 0.44 | 0.44 | 1.08 | 0.95 |
Excellent investment performance Low yielding FIS portfolio more than offset by private equities and real estates
| in m. EUR | Q2/2016 | Q2/2017 | 1H/2016 | 1H/2017 | RoI |
|---|---|---|---|---|---|
| Ordinary investment income* | 301 | 317 | 570 | 641 | 3.1% |
| Realised gains/losses | 36 | 59 | 80 | 83 | 0.4% |
| Impairments/appreciations & depreciations |
(34) | (12) | (48) | (23) | -0.1% |
| Change in fair value of financial instruments (through P&L) |
10 | (0) | 21 | 11 | 0.1% |
| Investment expenses | (26) | (28) | (52) | (56) | -0.3% |
| NII from assets under own mgmt. | 286 | 336 | 569 | 656 | 3.2% |
| NII from funds withheld | 92 | 50 | 176 | 123 | |
| Total net investment income | 379 | 387 | 745 | 779 | |
| Unrealised gains/losses of investments | 31 Dec 16 | 30 Jun 17 |
| 31 Dec 16 | 30 Jun 17 | |
|---|---|---|
| On Balance-sheet | 1,355 | 1,410 |
| thereof Fixed income AFS | 728 | 758 |
| Off Balance-sheet | 509 | 456 |
| thereof Fixed income HTM, L&R | 370 | 317 |
| Total | 1,864 | 1,866 |
YTD
- Higher ordinary income despite lower yielding fixed income portfolio due to high - partially extraordinary - income from private equity as well as higher income from real estate funds and amortisation
- Realised gains stable
- Decrease in impairments mostly attributable to listed and private equities
- Stable valuation reserves; balanced effects from higher interest rates and lower credit spreads
* Incl. results from associated companies
Ordinary income supported by less liquid asset classes Low yield environment has major impact on government bonds
Asset allocation
| Investment category | 30 Jun 17 |
|---|---|
| Fixed-income securities | 86 % |
| - Governments | 28 % |
| - Semi-governments | 17 % |
| - Corporates | 32 % |
| Investment grade | 27 % |
| Non-investment grade | 5 % |
| - Pfandbriefe, Covered Bonds, ABS | 8 % |
| Equities | 4 % |
| - Listed Equity | 2 % |
| - Private Equity | 2 % |
| Real estate/real estate funds | 5 % |
| Others | 1 % |
| Short-term investments & cash | 4 % |
| Total market values in bn. EUR | 40.8 |
Economic view based on market values as at 30 June 2017 * Before real estate-specific costs
Target Matrix 2017 Profit targets largely achieved
| Business group | Key figures | Strategic targets for 2017 |
1H/2017 |
|---|---|---|---|
| Group | Return on investment1) | >2.7% | 3.2% |
| Return on equity2) | ≥9.7% | 12.2% | |
| Earnings per share growth (y-o-y) | ≥6.5% | 9.6% | |
| Value creation per share3) | ≥7.5% | n.a. | |
| Property & Casualty R/I | Gross premium growth | 3% - 5% | 16.9% |
| Combined ratio | ≤96% | 96.5% | |
| EBIT margin6) | ≥10% | 14.7% | |
| xRoCA7) | ≥2% | n.a. | |
| Life & Health R/I | Gross premium growth | 5% - 7% | -1.5% |
| Value of New Business (VNB)9) | ≥ EUR 220 m. | n.a. | |
| EBIT margin6) Financial solutions/Longevity | ≥2% | 15.6% | |
| EBIT margin6) Mortality/Morbidity | ≥6% | 1.0% | |
| xRoCA7) | ≥3% | n.a. | |
| 1) Excl. effects from ModCo derivatives |
2) After tax; target: 900 bps above 5-year average return of 10-year German government bonds |
5) Incl. expected net major losses of EUR 825 m. 6) EBIT/net premium earned
9) Based on a cost of capital of 6% (until 2014: 4.5%)
3) Growth in book value per share + paid dividend 4) On average throughout the R/I cycle; at unchanged f/x rates
7) Excess return on allocated economic capital 8) Organic growth only; annual average growth (5 years), at unchanged f/x rates
Outlook 2017
10% premium growth deriving mostly from North America Property & Casualty treaty renewals: 2 April - 1 July 2017
Overall premium increase in North America of ~15%
- Increased our participation levels on several core accounts in property as rate pressure continues to moderate
- Casualty business remains quite competitive with pressure for further extension of coverages; however, we slightly enlarged our premium, partially due to new cyber business
- Strong increase in medical malpractice still considered competitive but we are expecting full margins on unique new transactions
- Favourable development in Australasia resulted in premium growth
- Negotiated suitable outcomes thanks to our positioning and security
- Concluded new business but reduced line size or even exited some programmes when under-priced as market remains challenging
- Global Cat
- Partially unchanged premium volume
- Positive development in Australia offset by rate declines in other markets
- Credit, surety & political risks
- Growth of 10% comes primarily from new programmes as well as from higher shares on existing business
Underwriting year figures at unchanged f/x rates (31 December 2016)
Guidance for 2017
Hannover Re Group
| | Gross written premium1) | more than 5% |
|---|---|---|
| --- | ------------------------- | -------------- |
- Return on investment2) 3) more than 2.7%
- Group net income2) more than EUR 1 bn.
- Dividend payout ratio4) 35% 40% (If comfortable level of capitalisation remains unchanged, this ratio will increase through payment of another special dividend)
1) At unchanged f/x rates
2) Subject to no major distortions in capital markets and/or major losses in 2017 not exceeding the large loss budget of EUR 825 m.
3) Excluding effects from ModCo derivatives
4) Relative to group net income according to IFRS
Overall profitability still above margin requirements Property & Casualty reinsurance: mixed picture by line of business
| Lines of business | Volume1) | Profitability2) | |
|---|---|---|---|
| Target | North America3) | +/- | |
| markets | Continental Europe3) | + | |
| Marine | + | ||
| Aviation | - | ||
| Specialty lines |
Credit, surety and political risks | +/- | |
| worldwide | UK, Ireland, London market and direct | - | |
| Facultative reinsurance | + | ||
| Worldwide treaty3) reinsurance | +/- | ||
| Global reinsurance |
Cat XL | - | |
| Structured reinsurance and ILS | +/- |
1) In EUR, development in original currencies can be different
2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)
3) All lines of business except those stated separately
Good underlying profitability affected by legacy US mortality
| Reporting categories | Volume1) | Profitability2) | |
|---|---|---|---|
| Financial solutions |
Financial solutions | ++ | |
| Longevity | +/- | ||
| Risk solutions |
Mortality | - | |
| Morbidity | +/- |
1) In EUR; development in original currencies can be different
2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)
We are confident of achieving the guidance. . . . . .despite reduced expectation for L&H in 2017
Appendix
Our strategic business groups at a glance 1H/2017 vs. 1H/2016
| Property & Casualty R/I | Life & Health R/I | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| in m. EUR | 1H/2016 | 1H/2017 | Δ | 1H/2016 | 1H/2017 | Δ | 1H/2016 | 1H/2017 | Δ |
| Gross written premium | 4,627 | 5,427 | +17.3% | 3,656 | 3,570 | -2.4% | 8,284 | 8,998 | +8.6% |
| Net premium earned | 3,838 | 4,313 | +12.4% | 3,328 | 3,210 | -3.6% | 7,167 | 7,523 | +5.0% |
| Net underwriting result | 166 | 149 | -10.5% | (169) | (228) | 34.8% | (3) | (79) | - |
| Net underwritung result incl. funds withheld | 178 | 151 | -15.3% | (5) | (106) | - | 173 | 45 | -74.2% |
| Net investment income | 416 | 476 | +14.3% | 322 | 302 | -6.3% | 745 | 779 | +4.6% |
| From assets under own management | 405 | 474 | +17.1% | 158 | 180 | +14.0% | 569 | 656 | +15.3% |
| From funds withheld | 12 | 2 | -84.2% | 164 | 122 | -25.9% | 176 | 123 | -29.7% |
| Other income and expenses | (20) | 10 | - | 26 | 91 | - | 5 | 99 | - |
| Operating profit/loss (EBIT) | 563 | 634 | +12.7% | 179 | 165 | -7.8% | 747 | 799 | +7.0% |
| Interest on hybrid capital | 0 | 0 | - | 0 | 0 | - | (36) | (36) | -0.2% |
| Net income before taxes | 563 | 634 | +12.7% | 179 | 165 | -7.8% | 711 | 764 | +7.4% |
| Taxes | (159) | (155) | -2.0% | (46) | (47) | +1.7% | (195) | (190) | -2.6% |
| Net income | 404 | 479 | +18.5% | 133 | 118 | -11.1% | 516 | 574 | +11.1% |
| Non-controlling interest | 26 | 35 | +33.6% | 2 | 4 | +72.2% | 28 | 39 | +36.8% |
| Group net income | 378 | 444 | +17.4% | 131 | 114 | -12.6% | 488 | 535 | +9.6% |
| Retention | 88.2% | 89.4% | 91.8% | 91.6% | 89.8% | 90.3% | |||
| Combined ratio (incl. interest on funds withheld) | 95.4% | 96.5% | 100.1% | 103.3% | 97.6% | 99.4% | |||
| EBIT margin (EBIT / Net premium earned) | 14.7% | 14.7% | 5.4% | 5.1% | 10.4% | 10.6% | |||
| Tax ratio | 28.2% | 24.5% | 25.8% | 28.5% | 27.4% | 24.9% | |||
| Earnings per share (in EUR) | 3.14 | 3.68 | 1.08 | 0.95 | 4.05 | 4.44 |
Our strategic business groups at a glance Q2/2017 vs. Q2/2016
| Property & Casualty R/I | Life & Health R/I | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| in m. EUR | Q2/2016 | Q2/2017 | Δ | Q2/2016 | Q2/2017 | Δ | Q2/2016 | Q2/2017 | Δ |
| Gross written premium | 2,125 | 2,613 | +22.9% | 1,895 | 1,838 | -3.0% | 4,020 | 4,451 | +10.7% |
| Net premium earned | 1,877 | 2,147 | +14.4% | 1,747 | 1,644 | -5.9% | 3,625 | 3,791 | +4.6% |
| Net underwriting result | 66 | 58 | -11.8% | (104) | (114) | +9.0% | (39) | (55) | - |
| Net underwritung result incl. funds withheld | 74 | 55 | -25.3% | (20) | (60) | - | 53 | (5) | -109.2% |
| Net investment income | 209 | 232 | +11.1% | 165 | 153 | -6.8% | 379 | 387 | +2.1% |
| From assets under own management | 201 | 235 | +16.9% | 80 | 100 | +24.5% | 286 | 336 | +17.3% |
| From funds withheld | 7 | (3) | -144.5% | 85 | 54 | -36.4% | 92 | 50 | -45.2% |
| Other income and expenses | (12) | 34 | - | 13 | 36 | +167.3% | 1 | 68 | - |
| Operating profit/loss (EBIT) | 263 | 324 | +23.4% | 74 | 75 | +2.5% | 340 | 400 | +17.5% |
| Interest on hybrid capital | 0 | (0) | - | 0 | (0) | - | (18) | (18) | +0.3% |
| Net income before taxes | 263 | 324 | +23.4% | 74 | 75 | +2.5% | 322 | 381 | +18.5% |
| Taxes | (78) | (79) | +1.0% | (19) | (22) | - | (93) | (94) | +1.2% |
| Net income | 185 | 246 | +32.7% | 54 | 54 | -0.5% | 230 | 287 | +25.2% |
| Non-controlling interest | 11 | 17 | +50.5% | 1 | 0 | -80.5% | 13 | 17 | +35.7% |
| Group net income | 174 | 229 | +31.4% | 53 | 54 | +1.6% | 217 | 270 | +24.6% |
| Retention | 88.5% | 90.3% | 93.0% | 91.8% | 90.6% | 90.9% | |||
| Combined ratio (incl. interest on funds withheld) | 96.1% | 97.4% | 101.1% | 103.7% | 98.5% | 100.1% | |||
| EBIT margin (EBIT / Net premium earned) | 14.0% | 15.1% | 4.2% | 4.6% | 9.4% | 10.5% | |||
| Tax ratio | 29.7% | 24.3% | 26.4% | 28.6% | 28.8% | 24.6% | |||
| Earnings per share (in EUR) | 1.44 | 1.90 | 0.44 | 0.44 | 1.80 | 2.24 |
Barbell strategy visible in fixed income composition Only minor changes to asset allocation in first half of the year
Asset allocation1)
| Investment category | 2013 | 2014 | 2015 | 2016 | 30 Jun 17 |
|---|---|---|---|---|---|
| Fixed-income securities | 90% | 90% | 87% | 87% | 86% |
| - Governments | 19% | 21% | 26% | 28% | 28% |
| - Semi-governments | 20% | 19% | 17% | 18% | 17% |
| - Corporates | 36% | 36% | 34% | 33% | 32% |
| Investment grade | 33% | 33% | 30% | 28% | 27% |
| Non-investment grade3 ) |
3% | 3% | 4% | 4% | 5% |
| - Pfandbriefe, Covered Bonds, ABS | 15% | 14% | 10% | 9% | 2) 8% |
| Equities | 2% | 2% | 3% | 4% | 4% |
| - Listed Equity | <1% | <1% | 1% | 2% | 2% |
| - Private Equity | 2% | 2% | 2% | 2% | 2% |
| Real estate/real estate funds | 4% | 4% | 4% | 5% | 5% |
| Others3 ) |
1% | 1% | 1% | 1% | 1% |
| Short-term investments & cash | 4% | 4% | 5% | 4% | 4% |
| Total market values in bn. EUR | 32.2 | 36.8 | 39.8 | 42.3 | 40.5 |
1) Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments
of EUR 1,065.2 m. (EUR 1,036.8 m.) as at 30 June 2017
2) Of which Pfandbriefe and Covered Bonds = 74.4%
3) Reallocation of High Yield Funds from "Others" to "Corporates – Non-investment grade"
Stress tests on assets under own management
Unchanged focus on yields and spreads while relevance of (private) equities rises
| Portfolio | Scenario | Change in market value in m. EUR |
Change in OCI before tax in m. EUR |
|
|---|---|---|---|---|
| -10% | -174 | -174 | ||
| Equity (listed and private equity) | -20% | -349 | -349 | |
| +50 bps | -864 | -776 | ||
| Fixed-income securities | +100 bps | -1,683 | -1,511 | |
| Credit spreads | +50% | -736 | -711 |
As at 30 June 2017
IV Conference Call on Half-yearly Report 2017
Fixed-income book well balanced Geographical allocation mainly in accordance with our business diversification
</bbb<>| Governments | Semi governments |
Corporates | Pfandbriefe, Covered bonds, ABS |
Short-term investments, cash |
Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AAA | 76.4% | 67.4% | 1.0% | 64.8% | - | 46.2% | ||||||
| A A |
11.4% | 24.6% | 11.9% | 13.5% | - | 14.5% | ||||||
| A | 6.3% | 3.3% | 33.8% | 7.4% | - | 15.7% | ||||||
| BBB | 4.1% | 1.3% | 43.9% | 10.0% | - | 18.5% | ||||||
| <bbb< td=""> | 1.9% | 3.4% | 9.3% | 4.2% | - | 5.1% | 1.9% | 3.4% | 9.3% | 4.2% | - | 5.1% |
| Total | 100.0% | 100.0% | 100.0% | 100.0% | - | 100.0% | ||||||
| Germany | 10.0% | 50.3% | 4.2% | 24.9% | 38.4% | 18.5% | ||||||
| UK | 6.6% | 2.5% | 8.1% | 9.5% | 4.7% | 6.5% | ||||||
| France | 1.6% | 2.1% | 8.4% | 5.5% | 0.7% | 4.4% | ||||||
| GIIPS | 1.2% | 1.0% | 4.9% | 4.6% | 0.0% | 2.7% | ||||||
| Rest of Europe | 3.9% | 14.4% | 17.1% | 25.3% | 4.6% | 12.4% | ||||||
| USA | 60.0% | 3.8% | 34.8% | 6.9% | 12.3% | 33.4% | ||||||
| Australia | 4.2% | 9.5% | 7.0% | 11.0% | 8.9% | 7.0% | ||||||
| Asia | 7.4% | 5.3% | 4.9% | 0.2% | 19.0% | 6.0% | ||||||
| Rest of World | 5.0% | 11.0% | 10.7% | 12.1% | 11.4% | 9.1% | ||||||
| Total | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | ||||||
| Total b/s values in m. EUR | 11,610 | 6,909 | 12,296 | 3,227 | 1,703 | 35,745 |
IFRS figures as at 30 June 2017
Currency allocation matches liability profile of balance sheet Duration-neutral strategy applied
Currency split of investments
- Modified duration of fixedincome mainly congruent with liabilities
- GBP's higher modified duration predominantly due to life business
Modified duration
| 2016 | 5.0 |
|---|---|
| 2015 | 4.4 |
| 2014 | 4.6 |
| 2013 | 4.4 |
| 2012 | 4.5 |
Modified duration as at 30 June 2017: 4.9
Solvency II ratio (regulatory view) Hannover Re Group
Development of the Solvency II ratio (regulatory view)
Q4/2015 Q2/2016 Q4/2016 Q1/2017
VII Conference Call on Half-yearly Report 2017
Disclaimer
This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities.
While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.
Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements.
This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re.
© Hannover Rück SE. All rights reserved.
Hannover Re is the registered service mark of Hannover Rück SE.